Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization

Eye (Basingstoke)

Volumn 26, Issue 8, 2012, Pages 1106-1113

  Grob, S ^a,b   Luo, J ^a,b   Hughes, G ^b   Lee, C ^b   Zhou, X ^b   Lee, J ^a,b   Du, H ^a,b   Ferreyra, H ^a   Freeman, W R ^a   Kozak, I ^a   Zhang, K ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

age related macular degeneration; choroidal neovascularization; genetics; geographic atrophy

Indexed keywords

COMPLEMENT FACTOR H;

ADULT; AGED; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; GEOGRAPHIC ATROPHY; HUMAN; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 84864851015     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.107     Document Type: Article

References (22)

1. Age-Related Eye Disease Study Group. Potential public health impact of age-related eye disease study results. Arch Ophthalmol 2003; 121: 1621-1624.
2. Age-Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 2005; 123(11): 1484-1498.
3. Schatz H, McDonald HR. Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. Ophthalmology 1989; 96: 1541-1551.
4. Macular Photocoagulation Study Group. Risk factors for neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997; 115(6): 741-747.
5. Sunness JS, Gonzales-Baron J, Bressler NM, Hawkins B, Applegate CA. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 1999; 106: 910-919.
6. Swaroop A, Chew EY, Rickman CB, Abecasts GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009; 10: 19-43.
7. Thakkinatian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K et al. Systematic review and meta-analysis of the association between complement factor HY402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15: 2784-2790.
8. Ross RJ, Verma V, Rosenberg KI, Chan CC, Tuo J. Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol 2007; 2(3): 443-457.
9. Tang NP, Zhou B, Wang B, Yu RB. HTRA1 promotor polymorphism and risk of age-related macular degeneration: a meta-analysis. Am Epidemiol 19: 740-745.
10. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458-462.
11. Francis PJ, Hamon Sc, Ott J, Weleber RG, Klein ML. Polymorphisms in C2, CFB and C3 are associated with progression to advance age related macular degeneration associated with visual loss. J Med Genet 46: 300-307.
12. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007; 39: 1200-1201.
13. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007; 357: 553-561.
14. Klein ML, Ferris FL III, Francis PJ, Linblad AS, Chew EY, Hamon SC et al. Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology 2010; 117(8): 1554-1559.
15. Scholl HP, Fleckenstein M, Fritsche LG, Schmitz-Valckenberg S, Göbel A, Adrion C et al. CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One 2009; 4(10): e7418.
16. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007; 267(16): 1793-1800.
17. Cameron DJ, Yang Z, Gibbs D, Chen H, Kaminoh Y, Jorgesen A et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 2007; 6(9): 1122-1125.
18. Chen Y, Zeng J, Zhao C, Wang K, Trood E, Buehler J et al. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophtalmol 2011; 129(3): 344-351.
19. Dewan A, Lui M, Hartman S, Zhang SS, Liu DT, Zhao C et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314(5801): 989-992.
20. Sarks SH. Aging and degeneration in the macular region: a clinicopathologic study. Br J Ophthalmol 1976; 60: 324-341.
21. Green WR, Enger C. Age-related macular degeneration histopathologic studies. Ophthalmology 1993; 100: 1519-1535.
22. Mata NL, Tsivkovaskaia N, Bui TV. Revision therapeutics. Fenretinide reduces the incidence of choroidal neovascularization in patients with geographic atrophy. ARVO Annual Meeting, 2 May, 2011. Session 258. Poster 1652.